120 related articles for article (PubMed ID: 37300688)
1. SNHG14 facilitates cell proliferation in colorectal cancer through targeting KRAS via Hippo-YAP signaling.
Shen M; Su Y; Song S; Liu D; Liu Z; Chen D; Pan Y; Zhang L; Xu X
Cell Mol Biol (Noisy-le-grand); 2023 Mar; 69(3):64-68. PubMed ID: 37300688
[TBL] [Abstract][Full Text] [Related]
2. Long noncoding RNA SNHG14 accelerates cell proliferation, migration, invasion and suppresses apoptosis in colorectal cancer cells by targeting miR-944/KRAS axis through PI3K/AKT pathway.
Pei Q; Liu GS; Li HP; Zhang Y; Xu XC; Gao H; Zhang W; Li T
Eur Rev Med Pharmacol Sci; 2019 Nov; 23(22):9871-9881. PubMed ID: 31799655
[TBL] [Abstract][Full Text] [Related]
3. Long noncoding RNA SNHG14 facilitates colorectal cancer metastasis through targeting EZH2-regulated EPHA7.
Di W; Weinan X; Xin L; Zhiwei Y; Xinyue G; Jinxue T; Mingqi L
Cell Death Dis; 2019 Jul; 10(7):514. PubMed ID: 31273190
[TBL] [Abstract][Full Text] [Related]
4. SNHG14 promotes the tumorigenesis and metastasis of colorectal cancer through miR-32-5p/SKIL axis.
Ye T; Zhang N; Wu W; Yang B; Wang J; Huang W; Tang D
In Vitro Cell Dev Biol Anim; 2019 Dec; 55(10):812-820. PubMed ID: 31471872
[TBL] [Abstract][Full Text] [Related]
5. Upregulation of SNHG14 suppresses cell proliferation and metastasis of colorectal cancer by targeting miR-92b-3p.
Zhang W; Duan W; Mo Z; Wang J; Yang W; Wu W; Li X; Lin S; Tan Y; Wei W
J Cell Biochem; 2020 Feb; 121(2):1998-2008. PubMed ID: 31692034
[TBL] [Abstract][Full Text] [Related]
6. SNHG14 stimulates cell autophagy to facilitate cisplatin resistance of colorectal cancer by regulating miR-186/ATG14 axis.
Han Y; Zhou S; Wang X; Mao E; Huang L
Biomed Pharmacother; 2020 Jan; 121():109580. PubMed ID: 31704614
[TBL] [Abstract][Full Text] [Related]
7. Oncogenic KRAS mutations enhance amino acid uptake by colorectal cancer cells via the hippo signaling effector YAP1.
Kandasamy P; Zlobec I; Nydegger DT; Pujol-Giménez J; Bhardwaj R; Shirasawa S; Tsunoda T; Hediger MA
Mol Oncol; 2021 Oct; 15(10):2782-2800. PubMed ID: 34003553
[TBL] [Abstract][Full Text] [Related]
8. Exploring the Therapeutic Potential of Fe
Mahdavi Niyaki Z; Salehzadeh A; Peymani M; Zaefizadeh M
Biol Trace Elem Res; 2024 Jul; 202(7):3073-3085. PubMed ID: 37792268
[TBL] [Abstract][Full Text] [Related]
9. LncRNA SPINT1-AS1/miR-433-3p/E2F3 positive feedback loop promotes the KRAS-mutant colorectal cancer cell proliferation, migration and invasion.
Sui X; Hu N; Wang P; Wang Y; Meng C; Zhang Z
Pathol Res Pract; 2022 Nov; 239():154064. PubMed ID: 36274378
[TBL] [Abstract][Full Text] [Related]
10. SLC25A22 Promotes Proliferation and Survival of Colorectal Cancer Cells With KRAS Mutations and Xenograft Tumor Progression in Mice via Intracellular Synthesis of Aspartate.
Wong CC; Qian Y; Li X; Xu J; Kang W; Tong JH; To KF; Jin Y; Li W; Chen H; Go MY; Wu JL; Cheng KW; Ng SS; Sung JJ; Cai Z; Yu J
Gastroenterology; 2016 Nov; 151(5):945-960.e6. PubMed ID: 27451147
[TBL] [Abstract][Full Text] [Related]
11. Long noncoding RNA GAS5 inhibits progression of colorectal cancer by interacting with and triggering YAP phosphorylation and degradation and is negatively regulated by the m
Ni W; Yao S; Zhou Y; Liu Y; Huang P; Zhou A; Liu J; Che L; Li J
Mol Cancer; 2019 Oct; 18(1):143. PubMed ID: 31619268
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of colorectal cancer tumorigenesis by ursolic acid and doxorubicin is mediated by targeting the Akt signaling pathway and activating the Hippo signaling pathway.
Hu D; Meng RY; Nguyen TV; Chai OH; Park BH; Lee JS; Kim SM
Mol Med Rep; 2023 Jan; 27(1):. PubMed ID: 36382656
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA‑337 inhibits colorectal cancer progression by directly targeting KRAS and suppressing the AKT and ERK pathways.
Liu X; Wang Y; Zhao J
Oncol Rep; 2017 Nov; 38(5):3187-3196. PubMed ID: 29048669
[TBL] [Abstract][Full Text] [Related]
14. ARID1A facilitates KRAS signaling-regulated enhancer activity in an AP1-dependent manner in colorectal cancer cells.
Sen M; Wang X; Hamdan FH; Rapp J; Eggert J; Kosinsky RL; Wegwitz F; Kutschat AP; Younesi FS; Gaedcke J; Grade M; Hessmann E; Papantonis A; Strӧbel P; Johnsen SA
Clin Epigenetics; 2019 Jun; 11(1):92. PubMed ID: 31217031
[TBL] [Abstract][Full Text] [Related]
15. Long noncoding RNA CRNDE stabilized by hnRNPUL2 accelerates cell proliferation and migration in colorectal carcinoma via activating Ras/MAPK signaling pathways.
Jiang H; Wang Y; Ai M; Wang H; Duan Z; Wang H; Zhao L; Yu J; Ding Y; Wang S
Cell Death Dis; 2017 Jun; 8(6):e2862. PubMed ID: 28594403
[TBL] [Abstract][Full Text] [Related]
16. DNA methylation-regulated and tumor-suppressive roles of miR-487b in colorectal cancer via targeting MYC, SUZ12, and KRAS.
Chen X; Lin ZF; Xi WJ; Wang W; Zhang D; Yang F; Li YF; Huo Y; Zhang TZ; Jiang YH; Qin WW; Yang AG; Wang T
Cancer Med; 2019 Apr; 8(4):1694-1709. PubMed ID: 30791232
[TBL] [Abstract][Full Text] [Related]
17. In Colorectal Cancer Cells With Mutant KRAS, SLC25A22-Mediated Glutaminolysis Reduces DNA Demethylation to Increase WNT Signaling, Stemness, and Drug Resistance.
Wong CC; Xu J; Bian X; Wu JL; Kang W; Qian Y; Li W; Chen H; Gou H; Liu D; Yat Luk ST; Zhou Q; Ji F; Chan LS; Shirasawa S; Sung JJ; Yu J
Gastroenterology; 2020 Dec; 159(6):2163-2180.e6. PubMed ID: 32814111
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-543 suppresses colorectal cancer growth and metastasis by targeting KRAS, MTA1 and HMGA2.
Fan C; Lin Y; Mao Y; Huang Z; Liu AY; Ma H; Yu D; Maitikabili A; Xiao H; Zhang C; Liu F; Luo Q; Ouyang G
Oncotarget; 2016 Apr; 7(16):21825-39. PubMed ID: 26968810
[TBL] [Abstract][Full Text] [Related]
19. 4-Acetyl-Antroquinonol B Improves the Sensitization of Cetuximab on Both Kras Mutant and Wild Type Colorectal Cancer by Modulating the Expression of Ras/Raf/miR-193a-3p Signaling Axis.
Chu YC; Tsai TY; Yadav VK; Deng L; Huang CC; Tzeng YM; Yeh CT; Chen MY
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299137
[TBL] [Abstract][Full Text] [Related]
20. Quadruple-editing of the MAPK and PI3K pathways effectively blocks the progression of KRAS-mutated colorectal cancer cells.
Wang Z; Kang B; Gao Q; Huang L; Di J; Fan Y; Yu J; Jiang B; Gao F; Wang D; Sun H; Gu Y; Li J; Su X
Cancer Sci; 2021 Sep; 112(9):3895-3910. PubMed ID: 34185934
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
